{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:54:09Z","timestamp":1767650049660,"version":"3.44.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.mcna.2021.02.001","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T17:10:40Z","timestamp":1617383440000},"page":"397-407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Eye Disease in Medical Practice"],"prefix":"10.1016","volume":"105","author":[{"given":"Carol H.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Bryar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2021.02.001_bib1","unstructured":"Available at: http:\/\/www.goodreads.com\/quotes\/13639-the-doctor-of-the-futre-will-give-no-medication-but. Accessed September 19, 2020."},{"issue":"7","key":"10.1016\/j.mcna.2021.02.001_bib3","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamaophthalmol.2016.1284","article-title":"Visual Impairment and Blindness in Adults in the United States","volume":"134","author":"Varma","year":"2016","journal-title":"JAMA Ophthalmol"},{"year":"2014","series-title":"The future of vision: Forecasting the prevalence and cost of vison problems","author":"Wittenborn","key":"10.1016\/j.mcna.2021.02.001_bib5"},{"key":"10.1016\/j.mcna.2021.02.001_bib6","unstructured":"Available at: https:\/\/www.norc.org\/Research\/Projects\/Pages\/the-economic-burden-of-vision-loss-and-eye-disorders-in-the-united-states.aspx#:-:text Accessed September 13, 2020."},{"issue":"6","key":"10.1016\/j.mcna.2021.02.001_bib7","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/jamaophthalmol.2019.0446","article-title":"MS association of vison loss with hospital use and costs among older adults","volume":"137","author":"Morse","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.mcna.2021.02.001_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/09286586.2019.1611879","article-title":"Ophthalmic Blindness and VI in the Medicare population: disparities and association with hip fracture and neuropsychiatric outcome","volume":"26","author":"Hamedani","year":"2019","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.mcna.2021.02.001_bib9","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/s41598-018-20374-5","article-title":"Visual impairment and risk of depression. A longitudinal follow-up study using a national sample cohort","volume":"8","author":"Choi","year":"2018","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.mcna.2021.02.001_bib10","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jamaophthalmol.2017.2838","article-title":"Association of Vision Loss with Cognition in Older Adults","volume":"135","author":"Chen","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.mcna.2021.02.001_bib11","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2337\/diab.44.8.968","article-title":"The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial","volume":"44","year":"1995","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.mcna.2021.02.001_bib14","first-page":"312","article-title":"Epidemiology of Eye-Related Emergency Department Visits","volume":"134","author":"Roomasa","year":"2016","journal-title":"Ophthalmology"},{"year":"2015","series-title":"2016 AAO preferred practice patterns","author":"Stephen","key":"10.1016\/j.mcna.2021.02.001_bib15"},{"issue":"3","key":"10.1016\/j.mcna.2021.02.001_bib16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2337\/dc16-2641","article-title":"Diabetic Retinopathy: A Position Statement by the American Diabetes Association","volume":"40","author":"Solomon","year":"2017","journal-title":"Diabetes Care"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712521000171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712521000171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:45:19Z","timestamp":1758419119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712521000171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0025712521000171"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2021.02.001","relation":{},"ISSN":["0025-7125"],"issn-type":[{"type":"print","value":"0025-7125"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eye Disease in Medical Practice","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2021.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}